V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310003168 | 310001347 | null | 110.7 | Palliative (P) | 2016-09-06 | 2016-09-06 | Trial Unspecified | Y | null | 310017384 | TRIAL |
| 310003169 | 310006545 | 1.55 | 86.9 | Palliative (P) | 2013-07-12 | 2013-07-21 | Trial Unspecified | N | N | 310017385 | TRIAL |
| 310003170 | 310001348 | 0.94 | 81.55 | Curative (C) | 2014-02-04 | 2014-02-05 | Retinoblastoma JOE | N | null | 310017390 | CEV |
| 310003171 | 310001349 | null | 61.6 | Adjuvant (A) | 2016-12-16 | 2016-12-16 | Cisplatin 7 day | 02 | N | 310017393 | CISPLATIN |
| 310003172 | 310001350 | 1.79 | 112.9 | null | 2016-03-01 | 2016-03-14 | Trial Unspecified | N | N | 310017394 | TRIAL |
| 310003173 | 310001351 | null | 58 | Palliative (P) | 2015-07-09 | 2015-07-12 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | 310017395 | CISPLATIN + GEMCITABINE |
| 310003174 | 310001351 | 1.62 | 69.1 | Palliative (P) | null | 2014-12-18 | PEMBROLIZUMAB | N | N | 310017395 | PEMBROLIZUMAB |
| 310003175 | 310001351 | null | null | Curative (C) | 2017-08-20 | 2017-09-03 | CHOP R | 02 | N | 310017395 | CHOP R |
| 310003176 | 310001352 | 1.58 | 49.7 | Palliative (P) | 2015-03-11 | 2015-03-11 | DOXORUBICIN | 02 | N | 310017400 | DOXORUBICIN |
| 310003177 | 310001352 | 1.82 | 83 | Palliative (P) | 2017-02-04 | 2017-02-11 | PEMBROLIZUMAB | 2 | N | 310017400 | PEMBROLIZUMAB |
| 310003178 | 310001353 | 1.62 | 71 | Palliative (P) | 2015-11-04 | 2015-11-04 | DOXORUBICIN | N | N | 310017403 | DOXORUBICIN |
| 310003179 | 310001353 | 1.6 | 67 | Curative (C) | 2017-11-06 | 2017-12-12 | Cisplatin 7 day | N | Y | 310017403 | CISPLATIN |
| 310003180 | 310001354 | 1.7 | 79 | Palliative (P) | 2014-08-20 | 2014-08-21 | PEMBROLIZUMAB | 02 | N | 310017405 | PEMBROLIZUMAB |
| 310003181 | 310001355 | 1.6 | 53 | null | 2013-07-09 | 2013-07-13 | Trial Unspecified | N | N | 310017406 | TRIAL |
| 310003182 | 310001356 | null | null | Adjuvant (A) | 2014-07-19 | 2014-08-13 | Cisplatin 7 day | N | Y | 310017407 | CISPLATIN |
| 310003183 | 310006549 | null | 85 | Palliative (P) | 2016-02-22 | 2016-02-23 | CHEMO-T TRIAL | Y | null | 310017409 | TRIAL |
| 310003184 | 310006549 | 1.68 | 59 | Palliative (P) | 2015-10-28 | 2015-10-29 | CHEMO-T TRIAL | Y | null | 310017409 | TRIAL |
| 310003185 | 310001357 | 1.73 | null | Palliative (P) | null | 2015-12-17 | DOXORUBICIN | null | null | 310017411 | DOXORUBICIN |
| 310003186 | 310006550 | 1.7 | 65.4 | Curative (C) | 2015-10-25 | 2015-11-01 | CHOP R | N | N | 310017412 | CHOP R |
| 310003187 | 310009009 | null | null | Palliative (P) | 2018-01-14 | 2018-01-22 | Ipilimumab | N | N | 310017413 | IPILIMUMAB |
| 310003188 | 310009009 | null | null | Palliative (P) | 2017-06-19 | 2017-06-24 | Ipilimumab | 02 | N | 310017413 | IPILIMUMAB |
| 310003189 | 310001358 | 1.75 | 62.5 | Neo-adjuvant (N) | 2013-07-16 | 2013-07-22 | CARBOPLATIN + ETOPOSIDE | N | N | 310017416 | CARBOPLATIN + ETOPOSIDE |
| 310003190 | 310006551 | 1.57 | 72 | Palliative (P) | 2015-05-13 | 2015-05-19 | Ipilimumab | 2 | null | 310017417 | IPILIMUMAB |
| 310003191 | 310006551 | 1.77 | 111 | Palliative (P) | 2014-05-28 | 2014-06-01 | CARBOPLATIN + ETOPOSIDE | N | N | 310017417 | CARBOPLATIN + ETOPOSIDE |
| 310003192 | 310006551 | 1.67 | 12.8 | Palliative (P) | 2017-02-16 | 2017-02-16 | Carboplatin + Etoposide IV 3 day | 2 | N | 310017417 | CARBOPLATIN + ETOPOSIDE |
| 310003193 | 310001359 | 1.47 | 57.8 | Curative (C) | 2014-08-21 | 2014-08-29 | CHOP R - 21 days | 2 | N | 310017421 | CHOP R |
| 310003194 | 310006552 | 1.72 | 10.8 | Palliative (P) | 2017-03-19 | 2017-03-28 | Carboplatin + Etoposide IV 3 day | N | N | 310017424 | CARBOPLATIN + ETOPOSIDE |
| 310003195 | 310006552 | 1.81 | 68 | Curative (C) | 2017-03-26 | 2017-04-03 | Cisplatin 7 day | N | N | 310017424 | CISPLATIN |
| 310003196 | 310006552 | null | 71.9 | Palliative (P) | 2016-03-27 | 2016-03-30 | CISPLATIN + GEMCITABINE | N | N | 310017424 | CISPLATIN + GEMCITABINE |
| 310003197 | 310001360 | 1.79 | 63.9 | Palliative (P) | 2013-04-23 | 2013-04-24 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | null | 310017428 | CISPLATIN + GEMCITABINE |
| 310003198 | 310001361 | 1.57 | 70 | Not known (9) | 2016-07-19 | 2016-07-20 | Ipilimumab | 02 | N | 310017429 | IPILIMUMAB |
| 310003199 | 310001361 | 1.51 | 62.3 | Adjuvant (A) | 2014-10-19 | 2014-10-19 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 310017429 | CISPLATIN + GEMCITABINE |
| 310003200 | 310009012 | null | 92 | Adjuvant (A) | 2015-07-09 | 2015-07-11 | Cisplatin | N | N | 310017434 | CISPLATIN |
| 310003201 | 310009012 | 1.65 | 73 | Adjuvant (A) | 2016-05-19 | 2016-06-02 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 310017434 | CISPLATIN + GEMCITABINE |
| 310003202 | 310009012 | 1.52 | 62.6 | Curative (C) | 2015-01-20 | 2015-02-14 | Cisplatin | N | Y | 310017434 | CISPLATIN |
| 310003203 | 310001362 | null | 123.4 | Adjuvant (A) | 2017-10-10 | 2017-10-22 | Cisplatin | 02 | Y | 310017446 | CISPLATIN |
| 310003204 | 310006554 | 1.63 | null | null | 2014-03-13 | 2014-03-16 | Trial Unspecified | Y | null | 310017452 | TRIAL |
| 310003205 | 310001363 | 1.47 | 92.7 | Curative (C) | 2016-02-24 | 2016-03-12 | Cisplatin 7 day | N | N | 310017453 | CISPLATIN |
| 310003208 | 310009013 | 1.83 | 64 | Palliative (P) | 2014-05-04 | 2014-05-16 | DOXORUBICIN | N | N | 310017461 | DOXORUBICIN |
| 310003209 | 310009013 | null | null | Not known (9) | 2015-03-31 | 2015-04-03 | Ipilimumab | N | N | 310017461 | IPILIMUMAB |
| 310003210 | 310009013 | 1.81 | 78.2 | Palliative (P) | 2015-12-25 | 2016-01-14 | CISPLATIN + GEMCITABINE | N | N | 310017461 | CISPLATIN + GEMCITABINE |
| 310003211 | 310009013 | 1.63 | 77.4 | Disease modification (D) | 2015-03-13 | 2015-03-21 | CHOP R - 21 days | 2 | N | 310017461 | CHOP R |
| 310003212 | 310001365 | 1.77 | 82.3 | Palliative (P) | 2015-12-06 | 2015-12-06 | Doxorubicin 75mg/m2 | null | N | 310017474 | DOXORUBICIN |
| 310003213 | 310001365 | 1.7 | 80.6 | Not known (9) | 2017-06-08 | 2017-06-16 | Carboplatin + Etoposide iv&po | N | N | 310017474 | CARBOPLATIN + ETOPOSIDE |
| 310003214 | 310001365 | 1.68 | 82.1 | Disease modification (D) | null | 2015-01-28 | Cisplatin 7 day | N | Y | 310017474 | CISPLATIN |
| 310003215 | 310001366 | null | 82 | null | 2018-03-19 | 2018-03-20 | Ipilimumab | N | N | 310017480 | IPILIMUMAB |
| 310003216 | 310001366 | null | 69 | Curative (C) | 2013-08-19 | 2013-09-02 | CHOP R | 99 | null | 310017480 | CHOP R |
| 310003217 | 310001367 | 1.6 | null | Curative (C) | 2017-06-11 | 2017-07-06 | Cisplatin | N | Y | 310017485 | CISPLATIN |
| 310003218 | 310006558 | 1.74 | 69.3 | Palliative (P) | null | 2017-07-10 | DOXORUBICIN | N | N | 310017486 | DOXORUBICIN |
| 310003219 | 310006558 | null | 57 | Disease modification (D) | 2016-01-09 | 2016-01-24 | Trial Unspecified | 02 | N | 310017486 | TRIAL |